Estimating the excess burden of pertussis disease in Australia within the first year of life, that might have been prevented through timely vaccination

Int J Epidemiol. 2023 Feb 8;52(1):250-259. doi: 10.1093/ije/dyac175.

Abstract

Background: Previous Australian studies have shown that delayed vaccination with each of the three primary doses of diphtheria-tetanus-pertussis-containing vaccines (DTP) is up to 50 % in certain subpopulations. We estimated the excess burden of pertussis that might have been prevented if (i) all primary doses and (ii) each dose was given on time.

Methods: Perinatal, immunization, pertussis notification and death data were probabilistically linked for 1 412 984 infants born in two Australian states in 2000-12. A DTP dose administered >15 days after the recommended age was considered delayed. We used Poisson regression models to compare pertussis notification rates to 1-year of age in infants with ≥1 dose delayed (Aim 1) or any individual dose delayed (Aim 2) versus a propensity weighted counterfactual on-time cohort.

Results: Of all infants, 42% had ≥1 delayed DTP dose. We estimated that between 39 to 365 days of age, 85 (95% CI: 61-109) cases per 100 000 infants, could have been prevented if all infants with ≥1 delayed dose had received their three doses within the on-time window. Risk of pertussis was higher in the delayed versus the on-time cohort, so crude rates overestimated the excess burden (110 cases per 100 000 infants (95% CI: 95-125)). The estimated dose-specific excess burden per 100 000 infants was 132 for DTP1, 50 for DTP2 and 19 for DTP3.

Conclusions: We provide robust evidence that improved DTP vaccine timeliness, especially for the first dose, substantially reduces the burden of infant pertussis. Our methodology, using a potential outcomes framework, is applicable to other settings.

Keywords: Pertussis; propensity score weighting; vaccination timeliness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Australia / epidemiology
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Female
  • Haemophilus Vaccines*
  • Humans
  • Infant
  • Pregnancy
  • Vaccination
  • Whooping Cough* / epidemiology
  • Whooping Cough* / prevention & control

Substances

  • Diphtheria-Tetanus-Pertussis Vaccine
  • Haemophilus Vaccines